Nimitt Consulting provides smart, cost-effective, and meaningful solutions for the health care industry. Nimitt’s expert services enhance our clients’ ability to implement and thrive under the wide range of regulatory initiatives and emerging technologies that affect the health care environment.

We specialize in helping domestic and international providers, governments, drug and device manufacturers, and other stakeholders respond to the evolving health care marketplace by providing advisory and advocacy services, case-mix development, and focused education and training programs.

Our philosophy is simple: we believe that implementing sustainable organizational change requires education, information, and open communication. We begin by helping decision-makers and front-line staff articulate their challenges and concerns. We then conduct analyses using quantitative and qualitative methods to create measurable solutions tailored to each client’s unique circumstance. We work with our clients every step of the way so they can successfully implement changes that improve health care delivery, quality, access, revenue, and compliance.

“Nimitt” means catalystrenewal, or progress. Our mission is to be a change agent to improve the health care system and our clients’ operational processes—with positive results for providers, payers, industry and, most importantly, the patients for whom they care.

 

Jugna Shah, MPH, President & Founder

Jugna Shah is a nationally recognized expert in health care policy, with more than 25 years of experience addressing the complex challenges of U.S. and international health care systems. As President, Jugna leads Nimitt’s team of experts who help providers, payers, professional organizations, and industry to not only to understand and thrive under existing payment systems, but also to create new models.

Jugna applies her in-depth expertise in payment systems and provider operations to identify effective reimbursement strategies. She has had notable successes in in oncology and stem cell transplant reimbursement improvements. Most recently, she led a multi-organization advocacy effort that successfully secured coverage for novel cell therapy, obtained new CPT and ICD-10 codes, and revised payment policies for innovative technologies to accurately reflect medical advancements and value them appropriately.

Jugna is also an international authority on designing and implementing case-mix based financing systems throughout Central and Eastern Europe. She is the former Vice President of Patient Classification Systems International (PCSI), the leading international organization on case-mix systems. Jugna has led numerous technical assistance initiatives through the World Bank, the World Health Organization, and US Agency for International Development to help foreign governments change (and improve) their health care financing systems.

Prior to founding Nimitt Consulting in 2000, Jugna was a Senior Manager with KPMG’s Assurance-Based Advisory Services Practice and an Ambulatory Care Product Marketing Manager at 3M Health Information Systems. Her knowledge of Medicare regulations and policies is honed by long experience: she has been engaged and involved with Medicare’s Diagnosis-Related Groups (DRGs) for her entire professional career, and was part of the team involved in creating what became Medicare’s Outpatient Prospective Payment System (OPPS), first implemented in 2000.

Jugna is a passionate advocate who applies her tactical and strategic problem-solving skills to improve health care delivery and access. A dynamic educator, Jugna thrives on helping clients understand complex and often arcane policies on coding, billing, coverage, and reimbursement. Her unique, non-nonsense style challenges and inspires clients—including executives who need the 30,000-foot perspective, and front-line staff implementing policies at the 1,000-foot level. Jugna is a popular speaker who regularly presents to provider and industry audiences on a wide range of topics, including at  conferences coordinated by TCT, AHLA, TFCA, HCPro, HFMA, AHIMA, and others.


EXPERT PARTNERS:


Valerie A. Rinkle, MPA, Principal

Valerie A. Rinkle has more than 35 years of expertise in advising clients on federal reimbursement systems, hospital finance and operations, compliance, and data analytics.

Valerie leads Nimitt’s strategic management projects to ensure provider and industry clients alike receive complete and compliant reimbursement. Her encyclopedic knowledge of the constantly changing regulations for providers is unparalleled in the field, and is especially critical as health care responds to the COVID-19 pandemic. Valerie uses data analytics to assess the most appropriate reimbursement strategy for services and products—including coding, new technology, and pass-through payment applications. In addition to her deep experience with provider operations, Valerie advises device, drug, and cellular therapy companies on market access and reimbursement strategies for new products, including novel therapies.

Valerie also has experience supporting mergers and acquisitions and analyzing defense strategies associated with Office of the Inspector General, Dept. of Justice, Recovery Audit Contractors, state Medicaid, and other audit agencies. She has also served as an expert witness in litigation associated with such audits.

Prior to joining Nimitt as a Principal in 2016, Valerie served as a health care system revenue cycle director for 10 years, and a consultant for Navigant Health Revenue Assurance Associates. She previously held leadership positions at the U.S. Dept. of Health and Human Services, including with the Assistant Secretary for Management and Budget (ASMB), Assistant Secretary for Planning and Evaluation (ASPE), and CMS (previously HCFA).

Valerie thrives on managing complicated revenue cycle optimization projects, ands ensuring patient access, regulatory compliance, adequate reimbursement, and back office enhancements. She has a 360-degree perspective, stemming from having held positions in all aspects of health care: drafting payer rules and policies as a federal employee; implementing operational and financial requirements as a provider; and now advising provider and industry clients on these issues as well as bringing new therapies to patients in a financially solvent manner. She is a popular and frequent presenter at national conferences, including the American Health Lawyers Association’s Institute of Medicare and Medicaid (MMI), TCT | Transplantation & Cellular Therapy Meetings, and HCPro’s Revenue Integrity Symposium (RIS). She also writes and presents on numerous reimbursement and regulatory issues affecting both providers and industry clients.


Susan K. Flinn, MA, Business Analyst

Susan K. Flinn has more than 25 years of public health experience in research, writing, editing, meeting management, and program coordination.

The author of numerous publications, Susan researches, drafts, and edits materials for a range of audiences, including policymakers, providers, and the general public. Her work has been published by Federal agencies, advocacy organizations, and public health associations. Susan is also an accomplished editor who has worked with non-profit and for-profit organizations to enhance their communications.

Susan helps clients hold effective meetings and capture the meeting outcomes. She plans agendas, objectives, and content; coordinates event invitations and logistics; provides on-site meeting oversight; and drafts reports and summaries of the proceedings.

Prior to forming her own company, Susan was a Federal lobbyist for a reproductive health organization, and a research assistant for a National Institutes of Mental Health (NIMH) study.


Amy Rinkle, Senior Policy Analyst

Amy is a Policy Analyst with Nimitt, focusing on innovative breakthrough therapies such as CAR-T.  She tracks new therapies, helps with understanding and communicating to the Nimitt team their mechanism of action, analyzing the coding and reimbursement implications, and she performs data collection and analysis to support Nimitt’s clients when examining payment implications, ROI, and policy impacts on commercialization plans.
Amy also focus on analyzing MIPS QPP reporting requirements and implementation for providers, CMMI and Alternative Payment Models comparison and developments, and assists with coding and billing review projects.

Amy specializes in process flow documentation and optimization, and has five years experience serving in business analysis roles.